Jade Biosciences Inc. (JBIO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Jade Biosciences Inc.

NASDAQ: JBIO · Real-Time Price · USD
8.86
0.53 (6.36%)
At close: Oct 03, 2025, 3:59 PM
8.35
-5.76%
After-hours: Oct 03, 2025, 05:57 PM EDT

Jade Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1K 4K 8K 218K 28K 28K 28K 25K
Gross Profit
-1K -4K -8K -218K -28K -28K -28K -25K
Operating Income
-27.78M -3.39M -6.4M -15.55M -26.16M -24.62M -22.07M -21.37M
Interest Income
1.83M 871K 1.03M 388K 1.4M 1.44M 1.71M 1.8M
Pretax Income
-32.13M -2.52M -5.38M -16.87M -24.77M -23.19M -20.36M -19.56M
Net Income
-32.13M -2.52M -5.43M -16.87M -24.77M -23.19M -20.41M -19.56M
Selling & General & Admin
5.23M 3.38M 4.86M 1.9M 4.89M 4.51M 4.22M 4.46M
Research & Development
22.55M n/a 1.53M 13.66M 21.25M 20.08M 17.81M 16.88M
Other Expenses
n/a n/a n/a 1.64M n/a n/a n/a n/a
Operating Expenses
27.78M 3.38M 6.39M 17.19M 26.14M 24.59M 22.04M 21.34M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
27.78M 3.39M 6.4M 15.55M 26.16M 24.62M 22.07M 21.37M
Income Tax Expense
n/a n/a 55K n/a n/a n/a 56K n/a
Shares Outstanding (Basic)
28.43M 828.14K 828.14K 824.67K 821.6K 794.17K 791.29K 789.73K
Shares Outstanding (Diluted)
28.43M 828.14K 828.14K 824.67K 821.6K 794.17K 791.29K 789.73K
EPS (Basic)
-1.13 -3.04 -6.56 -19.69 -30.15 -29.2 -25.8 -24.77
EPS (Diluted)
-1.13 -3.04 -6.56 -19.69 -30.15 -29.2 -25.8 -24.77
EBITDA
-32.13M -2.51M -5.37M -16.02M -24.75M -23.16M -20.33M -19.54M
EBIT
-32.13M -2.52M -5.38M -16.24M -24.77M -23.19M -20.36M -19.56M
Depreciation & Amortization
1K 4K 8K 218K 28K 28K 28K 25K